Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

Siscapa Assay Technologies, Inc.. (4/28/14). "Press Release: Siscapa Assay Technologies Appoints Gustavo Salem as President and CEO".

Organisation Organisation Siscapa Assay Technologies Inc. (SAT)
Products Product SISCAPA® assay (Stable Isotope Standards and Capture by Anti-Peptide Antibodies)
  Product 2 mass spectrometry (MS)
Persons Person Salem, Gustavo (Gus) (IDEX 201605 Group President of IDEX Health & Science before Siscapa + Agilent + Assay Designs)
  Person 2 Anderson, N. Leigh (Plasma Proteome Institute 200808 + SCISCAPA Assay Technologies)
     


SISCAPA Assay Technologies, Inc. (SAT), developer of precision mass spectrometry assays for quantitation of proteins, today announced the appointment of Gustavo (Gus) Salem to the position of President and CEO. For the past 18 months, Gus has served as a member of the board of directors and has worked closely with the company to evaluate strategic opportunities in the life science research and clinical diagnostics markets.

"We are extremely pleased to have Gus join the SAT team, and to drive our execution as a commercial stage company," said Leigh Anderson, SAT's founder, who continues as Chairman and Chief Scientific Officer. "Gus has already brought great value as an engaged board member based on a proven track-record in building teams, developing strategy and entering new markets. His familiarity with the company, technology and team will provide for a smooth and effective transition."

Gus brings over 25 years of life science and health science leadership experience to the position. Previously, while VP and General Manager of the Biological Systems Division at Agilent Technologies, he managed the mass spectrometry, genomics, and clinical diagnostics businesses amounting to >$500M annual sales. During his tenure, Agilent developed into a market-leading supplier of LC/MS and established market leadership in target enrichment sample prep for next generation DNA sequencing. Gus previously served as President and CEO of Assay Designs, Inc., a venture-backed company developing immunoassays and antibody reagents (now part of Enzo Life Sciences). Prior to Assay Designs he managed the Protein Separations Division of Bio-Rad Laboratories, which included product lines for chromatography and electrophoresis instruments and consumables.

"I want to thank Leigh and my fellow board members for this opportunity. We have identified some very exciting new diagnostic opportunities, and will continue to invest in the analytical and clinical validation of SISCAPA technology. The company is committed to our current partners and customers in improving access to the technology, and expanding our customer base through launch of new products and services," said Mr. Salem. "I am very excited to lead the team as we increase our focus on lab operations and commercial activities. We have great partners, strong revenue momentum, and an excellent strategy focused on empowering patients through improved clinical tests."


About SISCAPA Assay Technologies, Inc.

SISCAPA Assay Technologies Inc. (SAT) delivers tools for development of high-sensitivity, high-throughput specific assays for proteins, including clinical biomarkers, using SISCAPA® (Stable Isotope Standards and Capture by Anti-Peptide Antibodies) technology.

SISCAPA is a registered trademark of SISCAPA Assay Technologies Inc. in the United States and/or other countries. Additional information about SISCAPA technology, reagents and licensing is available at www.SISCAPA.com.

   
Record changed: 2016-03-19

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Siscapa Assay Technologies Inc. (SAT)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Partnering Opens 560x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Partnering Opens 560x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px